MedTrace Logo

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

NCT05704309 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1976

Last updated 2025-08-26

No results posted yet for this study

Summary

The DPPOS AD/ADRD project will address the overarching question: What are the determinants and the nature of cognitive impairment among persons with pre-diabetes (PreD) and type 2 diabetes (T2D), who are a high-risk group for cognitive impairment and represent a large fraction of the United States (US) population? This U19 proposal addresses the National Alzheimer's Project Act goal to "prevent, halt, or reverse AD" in the high-risk group of persons with pre-diabetes and type 2 diabetes, who represent over half of the population aged 60 years and older in the US.

Conditions

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Marinella Temprosa

    lead OTHER

Principal Investigators

  • Jose Luchsinger · Columbia University

  • David Nathan · Massachusetts General Hospital

  • Marinell Temprosa · George Washington University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-07
Primary Completion
2027-01-31
Completion
2027-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05704309 on ClinicalTrials.gov